GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GenMont Biotech Inc (TPE:3164) » Definitions » Net Income Including Noncontrolling Interests

GenMont Biotech (TPE:3164) Net Income Including Noncontrolling Interests : NT$29.5 Mil (TTM As of Mar. 2025)


View and export this data going back to 2008. Start your Free Trial

What is GenMont Biotech Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

GenMont Biotech's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2025 was NT$14.2 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 was NT$29.5 Mil.

GenMont Biotech Net Income Including Noncontrolling Interests Historical Data

The historical data trend for GenMont Biotech's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GenMont Biotech Net Income Including Noncontrolling Interests Chart

GenMont Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.22 109.60 47.46 22.43 47.75

GenMont Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.46 12.43 3.05 -0.19 14.19

GenMont Biotech Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$29.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GenMont Biotech Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of GenMont Biotech's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

GenMont Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GenMont Biotech Inc (TPE:3164) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
TPE:4133 ROCO:6872 ROCO:7776 ROCO:7427 ROCO:7806 ROCO:4168 ROCO:6846 ROCO:6810 ROCO:7773 ROCO:1295 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 8 Nanke 7th Road, Tainan Science and Technology Park, Shanhua District, Tainan, TWN, 741
Website
https://www.genmont.com.tw
GenMont Biotech Inc is engaged in the research, development, manufacturing, and selling of a variety of probiotic supplements. The Group mainly engages in the manufacturing and selling of functional foods, being its single operating segment.

GenMont Biotech Headlines

No Headlines